Compare Neurocrine Biosciences Inc (NBIX) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Virgin Galactic Holdings, Inc. — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Virgin Galactic Holdings, Inc. trades at $2.78 (market cap $329.06M). The key difference: Neurocrine Biosciences Inc is far larger — about 52.9× Virgin Galactic Holdings, Inc.'s market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals.
| NBIX | SPCE | |
|---|---|---|
Market Cap | $17.40B | $329.06M |
Sector | Health | Industrials |
52-Week High | $180.55 | $7.52 |
52-Week Low | $123.10 | $2.17 |
Enterprise Value | $16.49B | $428.90M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
